2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$8.63-$0.06 (-0.69%)
Price as of Oct 22, 2026 7:30 PM EDT- $468.6MMarket Cap
- 29.51%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$8.63-$0.06 (-0.69%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.69 | ||
Change | +$0.02 (+0.23%) | ||
Open | $8.72 | ||
High | $8.95 | ||
Low | $8.59 | ||
Previous Close | $8.67 | ||
Volume | 155,377 | ||
30-Day Average Volume | 239,434 | ||
1-Week Change | 13.45% | ||
1-Month Change | 19.70% | ||
1-Year Change | 29.51% | ||
3-Year Change | 304.19% | ||
5-Year Change | 105.92% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $45.0M | ||
Market Cap | $468.6M | ||
Enterprise Value | $463.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $46.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -46 | ||
PEG | 3 | ||
Price/Free Cash Flow | -52 | ||
Price/Operating Cash Flow | -52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue